drugset / Trial / NCT05618470

Wumeiwan Jiawei Fang Use in Patients With Blepharospasm

NCT05618470

Phase 2/3 Unknown 80 enrolled China Academy of Chinese Medical Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the efficacy and safety of Jing Fang Wu Mei Wan Jiawei Fang in the treatment of idiopathic blepharospasm using a clinical randomized controlled trial method.

Timeline

Start
2018-01-12
Primary completion
2024-08-30
Completion
2024-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 2.5 iu Other
Subject Wumeiwan Jiawei Fang Traditional medicine (herbal / TCM) Oral